Abeona Therapeutics Inc.
ABEO· Nasdaq
Released Mar 18, 2024, before the open
10-K filed Mar 18, 2024, 78 days after period end · 0001493152-24-010190
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $68.00K | — | — |
| Net Income | -$16.59M |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
| -$7.12M |
| -$46.68M |
| -$15.83M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.